Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRJ1-3024 in advanced melanoma
NCT06727630Phase 2Recruiting
- Sponsor
- Zhuhai Yufan Biotechnologies Co., Ltd.
- Start
- Mar 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of prj1-3024 in melanoma, sponsored by Zhuhai Yufan Biotechnologies Co., Ltd.. Started Mar 2024; status: recruiting.
02
Drugs
prj1-3024
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT06727630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06727630.